Copyright © 2024 Patentskart. All rights reserved
PatentsKart’s IP Analytics Dynamic Dashboard, powered by Tableau and Power BI, delivers customizable patent analytics that enable real-time monitoring of patent activity and provide actionable IP insights. This versatile platform supports informed R&D, innovation, and IP strategy decisions, helping organizations maximize the value of their patent portfolios and maintain a competitive edge.
PatentsKart streamlines navigation of the Standard Essential Patents (SEP) landscape with over 500,000 high-quality records, coverage across 15+ Standard Setting Organizations (SSOs), dynamic dashboards, and real-time updates. Our platform delivers actionable patent insights and competitive intelligence, enabling organizations to make informed IP strategy, R&D, and licensing decisions efficiently.
PatentsKart’s Purple Book data provides public access to detailed information on FDA-approved biologics and their associated patents, offering clear visibility into the IP landscape. By leveraging this resource, organizations can gain actionable patent insights, monitor biosimilar opportunities, and make informed IP strategy and R&D decisions.
The Orange Book, maintained by the FDA, provides comprehensive listings of FDA-approved chemical drugs and generics. PatentsKart simplifies the process of patent searching for these drugs, delivering actionable patent insights and supporting informed IP strategy, R&D, and licensing decisions.
Japan Pharma focuses on Japanese pharmaceutical patents, and PatentsKart provides comprehensive, up-to-date data on these patents. This resource delivers actionable patent insights, enabling organizations to monitor technology trends, assess competitive intelligence, and make informed IP strategy and R&D decisions in the Japanese pharmaceutical market.
Copyright © 2024 Patentskart. All rights reserved